Who Owns MRKR?

Marker Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$1.48

+0.08 (+5.71%)

Market Cap

$15.9M

Shares Outstanding

10,797,737

Institutional Holders

31

Total Inst. Value

$4.9M

% of Float Held

QoQ Holder Change

+7

Institutional data as of Q1 2025

New Positions

4

Closed Positions

4

Increased

10

Decreased

6

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1NEA Management Company, LLC$2.0M1,625,678
2Blue Owl Capital Holdings LP$682K554,250
3Hudson Bay Capital Management LP$615K499,730
4Aisling Capital Management LP$400K325,370
5VANGUARD GROUP INC$338K275,345
6Alyeska Investment Group, L.P.$322K261,777
7GEODE CAPITAL MANAGEMENT, LLC$108K88,669
8RENAISSANCE TECHNOLOGIES LLC$103K83,515
9LPL Financial LLC$90K73,227
10Squarepoint Ops LLCNew$53K43,302

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
Alyeska Investment Group, L.P.-654K$322K
NORTHERN TRUST CORP-43K$13K
LPL Financial LLC-7K$90K
BlackRock, Inc.-291$20K
FMR LLC-10$0

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold MRKR?

As of Q1 2025, 31 institutional investors report holding MRKR (Marker Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most MRKR?

The largest institutional holder of MRKR is NEA Management Company, LLC with $2.0M in shares.

Are institutions buying or selling MRKR?

This quarter, 4 institutions opened new positions in MRKR and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.